NCT01341457 2019-03-01A Study of LY2603618 in Combination With Gemcitabine in Participants With Solid TumorsEli Lilly and CompanyPhase 1 Completed17 enrolled 16 charts
NCT01296568 2019-01-07C14 Study in Oncology Patients With Advanced and/or Metastatic Solid TumorsEli Lilly and CompanyPhase 1 Completed3 enrolled 13 charts
NCT01358968 2018-10-25A Drug Interaction Study to Assess the Effect of LY2603618 on the Metabolic Pathway of DesipramineEli Lilly and CompanyPhase 1 Completed20 enrolled 14 charts